We are live on
!
Find out more
WINT
Windtree Therapeutics
WINT
WINT
Delisted
WINT was delisted on the 20th of August, 2025.
5 hedge funds and large institutions have $8.75K invested in Windtree Therapeutics in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0% more funds holding
Funds holding: 5 → 5 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
5.57% less ownership
Funds ownership: 6.04% → 0.46% (-5.6%)
85% less capital invested
Capital invested by funds: $57K → $8.75K (-$48.3K)
Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Jane Street
New York
|
+$12.9K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$741 |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$3 |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$25.5K |
| 2 |
Morgan Stanley
New York
|
-$18.9K |